Governance Otsuka Holdings Co., Ltd.

4578

JP3188220002

Pharmaceuticals

Delayed Japan Exchange Other stock markets 09:07:34 2025-02-16 pm EST			5-day change	1st Jan Change
7,553.00 ^JPY	+3.11%		-4.53%	-12.01%

Feb. 14	Otsuka Holdings Co., Ltd., 2024 Earnings Call, Feb 14, 2025
Feb. 07	Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ended December 2024	CI

Executive Committee: Otsuka Holdings Co., Ltd.

Manager

Positions heldSince

Makoto Inoue

66 year

Chief Executive Officer	2024-12-31
President	2024-12-31

Masanori Udagawa

Chief Tech/Sci/R&D Officer

Akiko Ryu

Human Resources Officer

Yozo Toba

67 year

Comptroller/Controller/Auditor

2018-02-28

Yuko Makino

63 year

Director of Finance/CFO

2018-02-28

Hiroki Nakayama

Comptroller/Controller/Auditor

Composition of the Board of Directors: Otsuka Holdings Co., Ltd.

Director

CommitteesSince

Ichiro Otsuka

60 year

Chairman

2015-02-28

Yoshiro Matsuo

64 year

Director/Board Member

2008-07-07

Yukio Matsutani

75 year

Director/Board Member	2016-02-29
Independent Dir/Board Member	2016-02-29

Masayuki Kobayashi

58 year

Director/Board Member

2017-03-29

Yuko Makino

63 year

Director/Board Member

2018-02-28

Ko Sekiguchi

76 year

Director/Board Member	2018-02-28
Independent Dir/Board Member	2018-02-28

Noriko Tojo

61 year

Director/Board Member

2008-08-19

Yoshihisa Aoki

73 year

Director/Board Member	2019-02-28
Independent Dir/Board Member	2019-02-28

Makoto Inoue

66 year

Director/Board Member

2020-03-26

Mayo Mita

64 year

Director/Board Member	2020-02-29
Independent Dir/Board Member	2020-02-29

Tatsuaki Kitachi

68 year

Director/Board Member	2022-02-28
Independent Dir/Board Member	2022-02-28

Shuichi Takagi

59 year

Director/Board Member

2019-02-28

Tatsuo Higuchi

74 year

Director/Board Member

2008-07-07

Latest Appointments: Otsuka Holdings Co., Ltd.

Otsuka Holdings Co., Ltd. and Otsuka Pharmaceutical Co., Ltd. Announces Changes of Representative Director	24-10-31	CI
Otsuka Holdings Co., Ltd. Announces CEO Changes	24-10-31	CI
Longeveron Names Lisa Locklear as CFO	23-07-20	MT
Japan's Nidec lines up five execs as chairman contenders	23-03-13	RE
KalVista Pharmaceuticals Appoints Brian J.G. Pereira Chairman to Succeed Martin Edwards	22-10-17	MT
COMPASS Pathways Names Kabir Nath CEO	22-07-19	MT
OptimizeRx : Hires Edward Stelmakh as CFO, COO	21-09-30	MT

More news

Former Officers and Directors: Otsuka Holdings Co., Ltd.

Insider

Positions held

SinceUntil

Tadaaki Kohnose

Director/Board Member	2014-05-31	2019-03-26
Independent Dir/Board Member	2014-05-31	2019-03-26

Yasuhisa Kurogi

Corporate Officer/Principal

2017-07-31

Tatsuro Watanabe

Director/Board Member

2014-05-31

2017-03-29

Robert Oliver

Chief Executive Officer	2015-12-31	2016-12-31
President	2015-12-31	2016-12-31

Akihito Nakai

Comptroller/Controller/Auditor

2014-05-31

2016-03-29

Juichi Kawaguchi

Director/Board Member	2013-05-31	2016-03-29
Independent Dir/Board Member	2013-05-31	2016-03-29

Norihiro Ashida

Chief Operating Officer

2003-03-31

2014-12-31

Akihiko Otsuka

Chairman

2008-07-07

2014-11-27

Yujiro Otsuka

Director/Board Member

2008-07-07

2014-06-26

Yukio Kobayashi

Director/Board Member

2008-07-07

2014-06-26

Takaharu Imai

Comptroller/Controller/Auditor

2014-05-31

Yasuyuki Hirotomi

Director/Board Member	2013-05-31	-
Independent Dir/Board Member	2013-05-31	-

Henrietta Ukwu

General Counsel

2012-12-31

Masahiko Kato

Comptroller/Controller/Auditor

2008-07-07

Masatoshi Taniguchi

Comptroller/Controller/Auditor

2011-07-10

Katsuya Yamasaki

Director/Board Member	2010-11-21	-
Corporate Officer/Principal	2009-06-08	-

Sadanobu Tobe

Comptroller/Controller/Auditor	2013-05-31	2014-05-31
Director/Board Member	2008-07-07	-

Atsumasa Makise

Director/Board Member	2008-07-07	-
Director of Finance/CFO	2008-07-07	2018-02-28

Kenichiro Otake

Director/Board Member

2011-07-10

Frank Czerwiec

Corporate Officer/Principal

1997-12-31

Kuniaki Natsume

Corporate Officer/Principal

Kiyotaka Otsubo

Comptroller/Controller/Auditor	-	-
Public Communications Contact	-	-

Takuma Kimura

Investor Relations Contact

Naoto Kondo

Public Communications Contact

Yuji Kogure

Investor Relations Contact

Toshifumi Arai

Comptroller/Controller/Auditor	-	-
Public Communications Contact	-	-

Age distribution of managers

Parity Men Women

Male	13
Female	4

Of which Executive Committee

Male	4
Female	2

Of which Directors

Male	10
Female	3

Revisions

1 year Revenue revision

4 months Revenue revision

1 months Revenue revision

1 year EPS revision

4 months EPS revision

ESG MSCI

ESG

StockField.ESG : Environnement

StockField.ESG : Social

StockField.ESG : Gouvernance

StockField.ESG : Polémique

ESG: Ethical controversies

ESG: Human rights controversies

ESG: Tax subsidies controversies

StockField.ESG : Conforme à la finance Islamique

Otsuka Holdings Co, Ltd. is a holding company organised around 4 areas of activity: - manufacture and sale of pharmaceutical products (65.2% of sales): prescription drugs and intravenous solutions mainly for the treatment of central nervous system disorders, cancer, cardiovascular, gastrointestinal and ophthalmic diseases. In addition, the group sells diagnostic products and medical devices; - manufacture and sale of nutraceutical products (25.1%): functional foods and beverages, OTC products, nutritional supplements; - production of mineral waters, beverages and foods (2.1%); - other (7.5%): manufacture of functional chemicals and fine chemicals, provision of logistics services, manufacture of electronic products, etc. Net sales by source of income are divided between sales of products (93.8%), sales of licences and royalties (1.8%) and other (4.4%). Net sales are distributed geographically as follows: Japan (43.2%), North America (34%),

Employees

34,388

Sector

Pharmaceuticals

Calendar

2025-05-08 - Q1 2025 Earnings Release (Projected)

More about the company